Search research articles
Contact Us
Filters
Showing results (11-20 of 78) with videos related to
Page
of 8
Sort By:
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
July 16, 2015
Continuous-Time Semi-Markov Models in Health Economic Decision Making: An Illustrative Example in Heart Failure Disease Management
Qi Cao, Erik Buskens, Talitha Feenstra, et al.
Nature Reviews. Clinical Oncology
|
December 7, 2021
The value of anticancer drugs - a regulatory view
Francesco Pignatti, Ulla Wilking, Douwe Postmus, et al.
Clinical Pharmacology and Therapeutics
|
May 13, 2025
Expedited Approval in Oncology: A Study of European Regulators' Perspectives and Trade-Offs
Francesco Pignatti, Filip Josephson, Pierre Demolis, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
July 12, 2013
A multi-criteria decision analysis perspective on the health economic evaluation of medical interventions
Douwe Postmus, Tommi Tervonen, Gert van Valkenhoef, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 7, 2011
Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer
Joachim Widder, Douwe Postmus, Jan F Ubbels, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
October 31, 2018
Stratified treatment recommendation or one-size-fits-all? A health economic insight based on graphical exploration
Qi Cao, Erik Buskens, Hans L Hillege, et al.
Statistics in Medicine
|
July 19, 2012
A method for the early health technology assessment of novel biomarker measurement in primary prevention programs
Douwe Postmus, Gimon de Graaf, Hans L Hillege, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 22, 2023
Attitudes of healthcare professionals and drug regulators about progression-free survival as endpoint in the advanced cancer setting
Douwe Postmus, Saskia Litiere, Jan Bogaerts, et al.
Journal of Clinical Epidemiology
|
December 27, 2011
Multicriteria benefit-risk assessment using network meta-analysis
Gert van Valkenhoef, Tommi Tervonen, Jing Zhao, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 16, 2025
Beyond traditional endpoints: A multi-state modelling approach to integrating morbidity and mortality in cancer treatments evaluation
Douwe Postmus, Jan J Cornelissen, Jan Bogaerts, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 78) with videos related to
Sort By:
Page
of 8
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
July 16, 2015
Continuous-Time Semi-Markov Models in Health Economic Decision Making: An Illustrative Example in Heart Failure Disease Management
Qi Cao, Erik Buskens, Talitha Feenstra, et al.
Nature Reviews. Clinical Oncology
|
December 7, 2021
The value of anticancer drugs - a regulatory view
Francesco Pignatti, Ulla Wilking, Douwe Postmus, et al.
Clinical Pharmacology and Therapeutics
|
May 13, 2025
Expedited Approval in Oncology: A Study of European Regulators' Perspectives and Trade-Offs
Francesco Pignatti, Filip Josephson, Pierre Demolis, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
July 12, 2013
A multi-criteria decision analysis perspective on the health economic evaluation of medical interventions
Douwe Postmus, Tommi Tervonen, Gert van Valkenhoef, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 7, 2011
Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer
Joachim Widder, Douwe Postmus, Jan F Ubbels, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
October 31, 2018
Stratified treatment recommendation or one-size-fits-all? A health economic insight based on graphical exploration
Qi Cao, Erik Buskens, Hans L Hillege, et al.
Statistics in Medicine
|
July 19, 2012
A method for the early health technology assessment of novel biomarker measurement in primary prevention programs
Douwe Postmus, Gimon de Graaf, Hans L Hillege, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 22, 2023
Attitudes of healthcare professionals and drug regulators about progression-free survival as endpoint in the advanced cancer setting
Douwe Postmus, Saskia Litiere, Jan Bogaerts, et al.
Journal of Clinical Epidemiology
|
December 27, 2011
Multicriteria benefit-risk assessment using network meta-analysis
Gert van Valkenhoef, Tommi Tervonen, Jing Zhao, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 16, 2025
Beyond traditional endpoints: A multi-state modelling approach to integrating morbidity and mortality in cancer treatments evaluation
Douwe Postmus, Jan J Cornelissen, Jan Bogaerts, et al.
Page
of 8